Theseus Pharmaceuticals CEO Timothy Clackson receives $7M in 2021
Theseus Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 26, 2023
Theseus Pharmaceuticals reported fiscal year 2021 executive compensation information on April 26, 2023.
In 2021, five executives at Theseus Pharmaceuticals received on average a compensation package of $2.5M, a 66% increase compared to previous year.
Average pay of disclosed executives at Theseus Pharmaceuticals
Timothy P. Clackson, Chief Executive Officer, received $7M in total. 92% of Clackson's compensation, or $6.4M, was in option awards. Clackson also received $196K in non-equity incentive plan and $372K in salary.
Bradford D. Dahms, Chief Financial Officer, received a compensation package of $1.9M. 81% of the compensation package, or $1.6M, was in option awards.
William C. Shakespeare, Co-Founder, earned $1.8M in 2021, a 10% increase compared to previous year.
David P. Kerstein, Chief Medical Officer, received $1.1M in 2021.
Iain D. Dukes, MA, Chief Executive Officer, earned $901K in 2021, a 38% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2023.